Latest / Logosofia no Dia a Dia
Beyond the FDA: Why Small Nations Re-Review Medicine
Why does a small country like Israel insist on its own regulatory review for drugs already greenlit by the FDA and EMA? In this episode, Herman and Corn dive into the complexities of pharmaceutical registration, examining the tension between national sovereignty and the need for speed. They explore the scientific justifications for local oversight—including genetic variations and environmental stability—and reveal the economic realities of the "Sal Briut" health basket. From the groundbreaking 2025 "Reliance Tracks" reform to the potential of joining the international Access Consortium, this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.